Boardroom Alpha
Boardroom Alpha
CVRX · Current Report (Form 8-K) · Filed June 9, 2026

Cvrx Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 9, 2026
Period
Jun 7, 2026
Ticker
CVRX
Accession
0001104659-26-071595
Boardroom Alpha · Filing insights

CVRx CFO Jared Oasheim resigns; will stay through transition, consulting through Feb 2027 with cash and option terms.

About Cvrx Inc
Market cap
$90M
1Y TSR
−48.2%
3Y TSR
−39.8%
Board grade
C
Sector
Healthcare
CEO
Kevin Hykes
Last annual meeting: Jun 1, 2026 · View full Cvrx Inc profile →

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 7, 2026

 

 

 

CVRx, Inc. 

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40545   41-1983744
(State or other jurisdiction of
incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

9201 West Broadway Avenue, Suite 650 

Minneapolis, MN 55445 

(Address of principal executive offices) (Zip Code)

 

(763) 416-2840 

(Registrant’s telephone number, including area code)

 

N/A 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange
on which registered
Common stock, par value $0.01 per share   CVRX   The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 7, 2026, Jared Oasheim, the Chief Financial Officer (“CFO”) of CVRx, Inc. (the “Company”), gave notice of his intention to resign from the Company to pursue other professional opportunities. Mr. Oasheim will remain CFO and continue serving as the principal accounting officer until his successor commences in the role and he will remain employed full-time with his current base salary until the later of August 31, 2026 or 30 days after the CFO transition. Subsequently, he will be available as a consultant through February 2027, compensated at an hourly rate of $245 per hour. On June 8, 2026, the Company and Mr. Oasheim entered into an Employment Transition Agreement reflecting the foregoing and, pursuant to which the Company agreed, contingent upon customary conditions and covenants: (i) that Mr. Oasheim would remain eligible for his full 2026 cash incentive payout based on the Company’s actual results even if his employment terminates prior to the date of payment, (ii) to pay Mr. Oasheim a cash payment of $262,000 for his commitment to assisting through the transition and consulting periods, payable in one-half increments on November 30, 2026 and February 28, 2027, (iii) to extend the post-termination exercise period of stock options issued to Mr. Oasheim prior July 2021 to three months following the end of the consulting period, and (iv) to reimburse his legal expenses for review of the transition agreement up to $10,000.

 

The Company is initiating a search to identify a successor CFO.

 

A press release announcing the foregoing is attached as Exhibit 99.1 to this Form 8-K, and the Employment Transition Agreement between the Company and Mr. Oasheim is attached as Exhibit 10.1.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
No.
  Description
10.1   Employment Transition Agreement between the Company and Jared Oasheim dated June 8, 2026
99.1   Press release of CVRx, Inc., dated June 9, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CVRx, Inc.
   
Date: June 9, 2026 By: /s/ Jared Oasheim
    Name: Jared Oasheim
    Its: Chief Financial Officer

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cvrx Inc (CVRX)

Reference

Frequently asked questions

When did Cvrx Inc file this 8-K?
Cvrx Inc (CVRX) filed this Current Report (Form 8-K) with the SEC on June 9, 2026. The accession number assigned by EDGAR is 0001104659-26-071595.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CVRx CFO Jared Oasheim resigns; will stay through transition, consulting through Feb 2027 with cash and option terms. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cvrx Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cvrx Inc has filed under CIK 1235912, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer